Clinical Trial Intelligence Dashboard

Real-time insights across all active trials and protocols

Live

24

Active Trials

+12%

47%

Avg Success Probability

Updated 2h ago

8,234

Enrolled Patients

Real-time

156

Active Simulations

Active Clinical Trials

Phase III Oncology - Solid Tumors

NCT-2024-045
342 patientsEnrolling
Simulate
Success Probability54%
Low Risk

Phase II Cardiovascular - Heart Failure

NCT-2024-038
189 patientsActive
Simulate
Success Probability41%
Medium Risk

Phase I Neurology - Alzheimer's

NCT-2024-052
0 patientsPlanning
Simulate
Success Probability32%
High Risk

Phase II Immunology - Autoimmune

NCT-2024-061
156 patientsEnrolling
Simulate
Success Probability67%
Low Risk

Risk Alerts

Enrollment Delay Risk

NCT-2024-038 - 34% behind target

Critical

Safety Signal Detected

NCT-2024-052 - Liver enzyme elevation

Monitor

Positive Interim Results

NCT-2024-061 - Exceeding efficacy threshold

On Track

Recent Activity

Simulation completed for NCT-2024-045

2 hours ago

New biomarker data integrated

5 hours ago

Patient stratification model updated

1 day ago

Run New Simulation

Test protocol modifications with counterfactual analysis

Start Simulation

Integrate Data Sources

Connect biomarkers, omics, and RWE data

Manage Data

Review Risk Forecast

View comprehensive risk analysis for all trials

View Forecast